Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × fezolinetant × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Specimen Handling 158 Magnetic Resonance Spectroscopy 131 Biopsy 100 pembrolizumab 95 Cyclophosphamide 75 Carboplatin 74 Paclitaxel 61 Cisplatin 60 Nivolumab 52 venetoclax 46 Radiotherapy 42 durvalumab 38 Gemcitabine 38 Rituximab 36 Bevacizumab 36 olaparib 35 fludarabine 35 Dexamethasone 35 atezolizumab 32 Radiation 32 Prednisone 31 Oxaliplatin 31 X-Rays 29 Ipilimumab 29 Fluorouracil 28 Docetaxel 28 Cytarabine 28 Etoposide 27 Lenalidomide 26 Doxorubicin 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06617455 2026-03-02

VEnT

University of Michigan Rogel Cancer Center

Phase 2 Terminated

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡